Skip to main content
Erschienen in: Cancer Chemotherapy and Pharmacology 6/2016

20.10.2016 | Original Article

Eriocitrin from lemon suppresses the proliferation of human hepatocellular carcinoma cells through inducing apoptosis and arresting cell cycle

verfasst von: Ziyou Wang, Hua Zhang, Jiahui Zhou, Xiangning Zhang, Liyong Chen, Kangxing Chen, Zunnan Huang

Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Hepatocellular carcinoma is a lethal cancer with high recurrence ratio and lacks effective therapeutics. In the past few years, it has been reported that increased intake of vegetables and fruits could reduce the cancer incidence, which suggests dietary agents might possess anticancer effects. Eriocitrin is a flavonoid isolated from lemon, which is known as a strong antioxidant agent. We here for the first time demonstrated that eriocitrin could inhibit the proliferation of hepatocellular carcinoma cell lines by arresting cell cycle in S phase through up-regulation of p53, cyclin A, cyclin D3 and CDK6. Furthermore, we found that eriocitrin could trigger apoptosis by activating mitochondria-involved intrinsic signaling pathway. Thus, eriocitrin might be regarded as a potential chemopreventive natural product to inhibit the early malignant transformation of hepatocellular carcinoma.
Literatur
1.
Zurück zum Zitat World Health Organization (WHO) (2014) Global battle against cancer won’t be won with treatment alone effective prevention measures urgently needed to prevent cancer crisis. Cent Eur J Publ Health 22(23):28 World Health Organization (WHO) (2014) Global battle against cancer won’t be won with treatment alone effective prevention measures urgently needed to prevent cancer crisis. Cent Eur J Publ Health 22(23):28
2.
4.
Zurück zum Zitat Lu SC (2010) Where are we in the chemoprevention of hepatocellular carcinoma? Hepatology 51:734–736PubMed Lu SC (2010) Where are we in the chemoprevention of hepatocellular carcinoma? Hepatology 51:734–736PubMed
7.
Zurück zum Zitat Reddy L, Odhav B, Bhoola KD (2003) Natural products for cancer prevention: a global perspective. Pharmacol Ther 99:1–13CrossRefPubMed Reddy L, Odhav B, Bhoola KD (2003) Natural products for cancer prevention: a global perspective. Pharmacol Ther 99:1–13CrossRefPubMed
8.
Zurück zum Zitat Lee KW, Bode AM, Dong Z (2011) Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer 11:211–218CrossRefPubMed Lee KW, Bode AM, Dong Z (2011) Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer 11:211–218CrossRefPubMed
9.
Zurück zum Zitat Gonzalez-Molina E, Dominguez-Perles R, Moreno DA, Garcia-Viguera C (2010) Natural bioactive compounds of Citrus limon for food and health. J Pharm Biomed Anal 51:327–345CrossRefPubMed Gonzalez-Molina E, Dominguez-Perles R, Moreno DA, Garcia-Viguera C (2010) Natural bioactive compounds of Citrus limon for food and health. J Pharm Biomed Anal 51:327–345CrossRefPubMed
10.
Zurück zum Zitat Li C, Zug C, Qu H, Schluesener H, Zhang Z (2015) Hesperidin ameliorates behavioral impairments and neuropathology of transgenic APP/PS1 mice. Behav Brain Res 281:32–42CrossRefPubMed Li C, Zug C, Qu H, Schluesener H, Zhang Z (2015) Hesperidin ameliorates behavioral impairments and neuropathology of transgenic APP/PS1 mice. Behav Brain Res 281:32–42CrossRefPubMed
11.
Zurück zum Zitat Bacanli M, Basaran AA, Basaran N (2015) The antioxidant and antigenotoxic properties of citrus phenolics limonene and naringin. Food Chem Toxicol 81:160–170CrossRefPubMed Bacanli M, Basaran AA, Basaran N (2015) The antioxidant and antigenotoxic properties of citrus phenolics limonene and naringin. Food Chem Toxicol 81:160–170CrossRefPubMed
12.
Zurück zum Zitat Banjerdpongchai R, Wudtiwai B, Khaw-On P, Rachakhom W, Duangnil N, Kongtawelert P (2016) Hesperidin from Citrus seed induces human hepatocellular carcinoma HepG2 cell apoptosis via both mitochondrial and death receptor pathways. Tumour Biol 37(1):227–237 Banjerdpongchai R, Wudtiwai B, Khaw-On P, Rachakhom W, Duangnil N, Kongtawelert P (2016) Hesperidin from Citrus seed induces human hepatocellular carcinoma HepG2 cell apoptosis via both mitochondrial and death receptor pathways. Tumour Biol 37(1):227–237
13.
Zurück zum Zitat Miyake Y, Yamamoto K, Tsujihara N, Osawa T (1998) Protective effects of lemon flavonoids on oxidative stress in diabetic rats. Lipids 33:689–695CrossRefPubMed Miyake Y, Yamamoto K, Tsujihara N, Osawa T (1998) Protective effects of lemon flavonoids on oxidative stress in diabetic rats. Lipids 33:689–695CrossRefPubMed
14.
Zurück zum Zitat K-i Minato, Miyake Y, Fukumoto S, Yamamoto K, Kato Y, Shimomura Y et al (2003) Lemon flavonoid, eriocitrin, suppresses exercise-induced oxidative damage in rat liver. Life Sci 72:1609–1616CrossRef K-i Minato, Miyake Y, Fukumoto S, Yamamoto K, Kato Y, Shimomura Y et al (2003) Lemon flavonoid, eriocitrin, suppresses exercise-induced oxidative damage in rat liver. Life Sci 72:1609–1616CrossRef
15.
Zurück zum Zitat Hiramitsu M, Shimada Y, Kuroyanagi J, Inoue T, Katagiri T, Zang L et al (2014) Eriocitrin ameliorates diet-induced hepatic steatosis with activation of mitochondrial biogenesis. Sci Rep 4:3708CrossRefPubMedPubMedCentral Hiramitsu M, Shimada Y, Kuroyanagi J, Inoue T, Katagiri T, Zang L et al (2014) Eriocitrin ameliorates diet-induced hepatic steatosis with activation of mitochondrial biogenesis. Sci Rep 4:3708CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Wang Y, Yu H, Zhang J, Gao J, Ge X, Lou G (2015) Hesperidin inhibits HeLa cell proliferation through apoptosis mediated by endoplasmic reticulum stress pathways and cell cycle arrest. BMC Cancer 15:682CrossRefPubMedPubMedCentral Wang Y, Yu H, Zhang J, Gao J, Ge X, Lou G (2015) Hesperidin inhibits HeLa cell proliferation through apoptosis mediated by endoplasmic reticulum stress pathways and cell cycle arrest. BMC Cancer 15:682CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Schrödinger Release 2015-2 (2015) Maestro, version 10.2, Schrödinger, LLC, New York Schrödinger Release 2015-2 (2015) Maestro, version 10.2, Schrödinger, LLC, New York
18.
Zurück zum Zitat Whitfield ML, George LK, Grant GD, Perou CM (2006) Common markers of proliferation. Nat Rev Cancer 6:99–106CrossRefPubMed Whitfield ML, George LK, Grant GD, Perou CM (2006) Common markers of proliferation. Nat Rev Cancer 6:99–106CrossRefPubMed
19.
Zurück zum Zitat Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL (2011) Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 11:558–572CrossRefPubMed Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL (2011) Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 11:558–572CrossRefPubMed
21.
Zurück zum Zitat Chen J (2016) The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression. Cold Spring Harb Perspect Med 6(3):a026104 Chen J (2016) The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression. Cold Spring Harb Perspect Med 6(3):a026104
23.
Zurück zum Zitat Delbridge AR, Grabow S, Strasser A, Vaux DL (2016) Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat Rev Cancer 16:99–109CrossRefPubMed Delbridge AR, Grabow S, Strasser A, Vaux DL (2016) Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat Rev Cancer 16:99–109CrossRefPubMed
24.
Zurück zum Zitat Liu K, Cho YY, Yao K, Nadas J, Kim DJ, Cho EJ et al (2011) Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation. J Biol Chem 286:2057–2066CrossRefPubMed Liu K, Cho YY, Yao K, Nadas J, Kim DJ, Cho EJ et al (2011) Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation. J Biol Chem 286:2057–2066CrossRefPubMed
27.
Zurück zum Zitat O’Leary B, Finn RS, Turner NC (2016) Treating cancer with selective CDK4/6 inhibitors. Nat Rev Clin Oncol 13(7):417–430 O’Leary B, Finn RS, Turner NC (2016) Treating cancer with selective CDK4/6 inhibitors. Nat Rev Clin Oncol 13(7):417–430
28.
Zurück zum Zitat Malumbres M, Barbacid M (2005) Mammalian cyclin-dependent kinases. Trends Biochem Sci 30:630–641CrossRefPubMed Malumbres M, Barbacid M (2005) Mammalian cyclin-dependent kinases. Trends Biochem Sci 30:630–641CrossRefPubMed
29.
Zurück zum Zitat Mateo F, Vidal-Laliena M, Canela N, Busino L, Martinez-Balbas MA, Pagano M et al (2009) Degradation of cyclin A is regulated by acetylation. Oncogene 28:2654–2666CrossRefPubMed Mateo F, Vidal-Laliena M, Canela N, Busino L, Martinez-Balbas MA, Pagano M et al (2009) Degradation of cyclin A is regulated by acetylation. Oncogene 28:2654–2666CrossRefPubMed
30.
Zurück zum Zitat Hydbring P, Malumbres M, Sicinski P (2016) Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases. Nat Rev Mol Cell Biol 17(5):280-292 Hydbring P, Malumbres M, Sicinski P (2016) Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases. Nat Rev Mol Cell Biol 17(5):280-292
31.
Zurück zum Zitat Inoue S, Browne G, Melino G, Cohen GM (2009) Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway. Cell Death Differ 16:1053–1061CrossRefPubMed Inoue S, Browne G, Melino G, Cohen GM (2009) Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway. Cell Death Differ 16:1053–1061CrossRefPubMed
32.
Zurück zum Zitat Sebolt-Leopold JS, Herrera R (2004) Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 4:937–947CrossRefPubMed Sebolt-Leopold JS, Herrera R (2004) Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 4:937–947CrossRefPubMed
33.
Zurück zum Zitat Manson MM (2003) Cancer prevention—the potential for diet to modulate molecular signalling. Trends Mol Med 9:11–18CrossRefPubMed Manson MM (2003) Cancer prevention—the potential for diet to modulate molecular signalling. Trends Mol Med 9:11–18CrossRefPubMed
34.
Zurück zum Zitat Henderson AJ, Ollila CA, Kumar A, Borresen EC, Raina K, Agarwal R et al (2012) Chemopreventive properties of dietary rice bran: current status and future prospects. Adv Nutr: Int Rev J 3:643–653CrossRef Henderson AJ, Ollila CA, Kumar A, Borresen EC, Raina K, Agarwal R et al (2012) Chemopreventive properties of dietary rice bran: current status and future prospects. Adv Nutr: Int Rev J 3:643–653CrossRef
Metadaten
Titel
Eriocitrin from lemon suppresses the proliferation of human hepatocellular carcinoma cells through inducing apoptosis and arresting cell cycle
verfasst von
Ziyou Wang
Hua Zhang
Jiahui Zhou
Xiangning Zhang
Liyong Chen
Kangxing Chen
Zunnan Huang
Publikationsdatum
20.10.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Cancer Chemotherapy and Pharmacology / Ausgabe 6/2016
Print ISSN: 0344-5704
Elektronische ISSN: 1432-0843
DOI
https://doi.org/10.1007/s00280-016-3171-y

Weitere Artikel der Ausgabe 6/2016

Cancer Chemotherapy and Pharmacology 6/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.